[News] All 12 Patients Off Insulin: A New Anti-Rejection Drug Lets Donor Islet Cells Do Their Job
Swapping tacrolimus for tegoprubart left all 12 trial patients producing their own insulin, but the cohort is small, follow-up is short, the drugs are lifelong and donor islets remain scarce.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.